MEMBER REWARDS - Earn free advertising by participating in these forums! Click here for details.
Welcome to Webmaster Forums 101!
You are currently viewing our boards as a guest which gives you limited access to view most discussions, articles and access our other FREE features. By joining our free community you will have access to post topics, communicate privately with other members (PM), respond to polls, upload your own photos and access many other special features. Registration is fast, simple and absolutely free so please, join our community today!
If you have any problems with the registration process or your account login, please contact contact support.
Reuters - Eli Lilly and Co. on Friday
said it plans to ask U.S. regulators next year to approve its
Cymbalta depression drug as a treatment for generalized anxiety
disorder, a move meant to boost the medicine's disappointing
sales growth.
Lilly to seek OK to market Cymbalta (Reuters)
Linear Mode
